ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2016/06/15 | 1,410 | 1,440 | 1,405 | 1,427 | +6 | +0.4% | 79,500 |
2016/06/14 | 1,460 | 1,460 | 1,417 | 1,421 | -55 | -3.7% | 81,200 |
2016/06/13 | 1,490 | 1,491 | 1,471 | 1,476 | -34 | -2.3% | 76,100 |
2016/06/10 | 1,525 | 1,525 | 1,502 | 1,510 | -12 | -0.8% | 98,900 |
2016/06/09 | 1,512 | 1,530 | 1,512 | 1,522 | -6 | -0.4% | 51,600 |
2016/06/08 | 1,500 | 1,528 | 1,495 | 1,528 | +28 | +1.9% | 89,900 |
2016/06/07 | 1,480 | 1,500 | 1,480 | 1,500 | +22 | +1.5% | 59,600 |
2016/06/06 | 1,467 | 1,478 | 1,452 | 1,478 | -11 | -0.7% | 60,800 |
2016/06/03 | 1,446 | 1,490 | 1,446 | 1,489 | +56 | +3.9% | 85,400 |
2016/06/02 | 1,457 | 1,463 | 1,426 | 1,433 | -45 | -3% | 111,100 |
2016/06/01 | 1,464 | 1,490 | 1,464 | 1,478 | -9 | -0.6% | 61,600 |
2016/05/31 | 1,477 | 1,489 | 1,460 | 1,487 | +3 | +0.2% | 165,400 |
2016/05/30 | 1,476 | 1,485 | 1,456 | 1,484 | +29 | +2% | 45,300 |
2016/05/27 | 1,487 | 1,487 | 1,450 | 1,455 | -26 | -1.8% | 61,400 |
2016/05/26 | 1,478 | 1,489 | 1,460 | 1,481 | +20 | +1.4% | 110,200 |
2016/05/25 | 1,489 | 1,493 | 1,459 | 1,461 | -1 | -0.1% | 56,200 |
2016/05/24 | 1,451 | 1,468 | 1,447 | 1,462 | +8 | +0.6% | 69,100 |
2016/05/23 | 1,431 | 1,456 | 1,420 | 1,454 | +11 | +0.8% | 81,600 |
2016/05/20 | 1,460 | 1,460 | 1,403 | 1,443 | -27 | -1.8% | 95,700 |
2016/05/19 | 1,488 | 1,493 | 1,461 | 1,470 | -5 | -0.3% | 64,000 |
2016/05/18 | 1,480 | 1,494 | 1,456 | 1,475 | -1 | -0.1% | 82,200 |
2016/05/17 | 1,460 | 1,486 | 1,453 | 1,476 | +29 | +2% | 148,200 |
2016/05/16 | 1,410 | 1,459 | 1,399 | 1,447 | +90 | +6.6% | 212,100 |
2016/05/13 | 1,363 | 1,375 | 1,342 | 1,357 | -14 | -1% | 133,900 |
2016/05/12 | 1,380 | 1,380 | 1,352 | 1,371 | -22 | -1.6% | 408,800 |
2016/05/11 | 1,402 | 1,412 | 1,372 | 1,393 | -1 | -0.1% | 90,600 |
2016/05/10 | 1,349 | 1,398 | 1,349 | 1,394 | +48 | +3.6% | 100,800 |
2016/05/09 | 1,340 | 1,355 | 1,337 | 1,346 | +22 | +1.7% | 51,000 |
2016/05/06 | 1,328 | 1,341 | 1,316 | 1,324 | +1 | +0.1% | 78,200 |
2016/05/02 | 1,350 | 1,360 | 1,319 | 1,323 | -57 | -4.1% | 101,600 |
2016/04/28 | 1,429 | 1,435 | 1,376 | 1,380 | -21 | -1.5% | 113,400 |
2016/04/27 | 1,417 | 1,417 | 1,395 | 1,401 | -8 | -0.6% | 62,600 |
2016/04/26 | 1,400 | 1,415 | 1,390 | 1,409 | +3 | +0.2% | 91,000 |
2016/04/25 | 1,438 | 1,440 | 1,404 | 1,406 | -29 | -2% | 118,900 |
2016/04/22 | 1,411 | 1,435 | 1,401 | 1,435 | +12 | +0.8% | 82,900 |
2016/04/21 | 1,428 | 1,432 | 1,411 | 1,423 | +15 | +1.1% | 88,400 |
2016/04/20 | 1,419 | 1,431 | 1,401 | 1,408 | -3 | -0.2% | 91,400 |
2016/04/19 | 1,413 | 1,420 | 1,398 | 1,411 | +28 | +2% | 77,300 |
2016/04/18 | 1,381 | 1,397 | 1,381 | 1,383 | -48 | -3.4% | 75,600 |
2016/04/15 | 1,402 | 1,436 | 1,402 | 1,431 | +11 | +0.8% | 72,000 |
2016/04/14 | 1,407 | 1,420 | 1,388 | 1,420 | +38 | +2.7% | 119,400 |
2016/04/13 | 1,383 | 1,394 | 1,369 | 1,382 | +16 | +1.2% | 89,100 |
2016/04/12 | 1,349 | 1,383 | 1,349 | 1,366 | +11 | +0.8% | 67,800 |
2016/04/11 | 1,360 | 1,366 | 1,337 | 1,355 | -16 | -1.2% | 67,800 |
2016/04/08 | 1,319 | 1,386 | 1,315 | 1,371 | +15 | +1.1% | 90,300 |
2016/04/07 | 1,318 | 1,364 | 1,310 | 1,356 | +32 | +2.4% | 73,000 |
2016/04/06 | 1,303 | 1,332 | 1,302 | 1,324 | +5 | +0.4% | 96,700 |
2016/04/05 | 1,355 | 1,372 | 1,315 | 1,319 | -53 | -3.9% | 126,000 |
2016/04/04 | 1,365 | 1,387 | 1,352 | 1,372 | +14 | +1% | 121,700 |
2016/04/01 | 1,431 | 1,434 | 1,352 | 1,358 | -103 | -7% | 200,000 |
2251~
2300
件表示中 / 3772件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 203,000円 | +3.1% | -6.5% | 2.36% | 9.42倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ジーエヌアイ | 265,700円 | +21.7% | +999.9% | 0.00% | 12.24倍 | 4.19倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 312,500円 | +5.1% | -7.0% | 2.56% | 20.51倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 247,300円 | +4.1% | -3.1% | 2.35% | 21.48倍 | 1.87倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
杏林製薬 | 151,400円 | -2.4% | -52.3% | 3.76% | 18.12倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム